Nurix Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Brisbane, CA
NRIX chart
What traders are saying about $NRIX
Latest postsNurix Therapeutics, Inc. news
- FMR LLC Trims Nurix Therapeutics Inc (NRIX) Stake -- Shares Trade 84% Below GF Value
GuruFocus ·
- Nurix Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- Three Nurix investor chats will be webcast and archived for 30 days.
Stock Titan ·
- Nurix Therapeutics, Inc. (NRIX) Options Chain - Yahoo Finance
Yahoo! Finance Canada ·
- Nurix Therapeutics, Inc. (NRIX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Does Phase 1 Drug Cancellation Change The Bull Case For Nurix Therapeutics (NRIX)?
Simply Wall St ·
- Is Early B Cell Cancer Data Altering The Investment Case For Nurix Therapeutics (NRIX)?
Yahoo Finance ·
- Nurix Therapeutics (NRIX) Gains On Bexobrutideg Data As Fair Value Debate Returns
Simply Wall St ·
- Nurix Therapeutics, Inc. (NRIX) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Nurix Therapeutics, Inc. $NRIX Shares Sold by Sumitomo Mitsui Trust Group Inc.
MarketBeat ·
- Cathie Wood Sells $12.8 Million Of Alphabet, Days After The Stock Suffered Its Worst Day Since Its 2004 IPO, Losing Nearly Half A Trillion Dollars In Market Value
247wallst.com ·
- H.C. Wainwright Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $36
Moomoo ·
Nurix Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $84.0M | $54.5M | $77.0M | $38.6M |
| Net income | -$264.5M | -$193.6M | -$143.9M | -$180.4M |
| Diluted EPS | $-3.05 | $-2.88 | $-2.65 | $-3.71 |
| Total assets (year end) | $688.1M | $669.3M | $355.6M | $416.8M |
| Cash and equivalents (year end) | $247.0M | $110.0M | $54.6M | $64.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Nurix Therapeutics, Inc.
- Ticker
- NRIX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Brisbane, CA
- Incorporated in
- DE
- Fiscal year end
- November 30
- SEC CIK
- 1549595
- Former names
- Nurix, Inc.
Frequently asked questions
What exchange is Nurix Therapeutics, Inc. listed on?
Nurix Therapeutics, Inc. trades on the Nasdaq under the ticker symbol NRIX.
What industry is Nurix Therapeutics, Inc. in?
Nurix Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Nurix Therapeutics, Inc. headquartered?
Nurix Therapeutics, Inc.'s business address on file with the SEC is in Brisbane, CA.
When does Nurix Therapeutics, Inc.'s fiscal year end?
Nurix Therapeutics, Inc.'s fiscal year ends on November 30.
How much revenue did Nurix Therapeutics, Inc. report?
Nurix Therapeutics, Inc. reported $84.0M in revenue for calendar year 2025, according to its SEC filings.